520 results
Page 2 of 26
8-K
EX-99.2
he6sc4 4v7e7cp3
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
x7m58vb5 s8vljha6j2u
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
S-8
EX-99.1
0mx1ou9t
17 Oct 22
Registration of securities for employees
4:02pm
8-K/A
EX-99.1
e3jjvsgah ljey
4 Oct 22
Other Events
4:42pm
8-K/A
EX-99.2
jfndamhi5un81lr8 xw6
4 Oct 22
Other Events
4:42pm
8-K/A
EX-99.3
9vpeqg bryutd
4 Oct 22
Other Events
4:42pm
8-K
EX-99.1
csizx
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
rjjgai7
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.2
h587g
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-10.2
ay5mphtnq12vl55ggvik
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.1
zxo4uk1p
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
irqhtssnab
2 Sep 22
Business combination disclosure
4:01pm
425
kjvo4lj6cvcrp 0r
15 Aug 22
Business combination disclosure
6:46am
425
292ibh
10 Aug 22
Business combination disclosure
8:08am
8-K
EX-99.1
zln3xt95
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.3
nucguuayuw 3t
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
gebpf599270
29 Jul 22
Prospectus supplement
4:06pm